GRFS CIK: 1438569

Grifols SA

  • Spain
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions EUR
FY21:
5.51
FY22:
4.69
FY23:
6.13
FY24:
5.73
FY25:
5.07
(positive)
Change from FY21 to FY25
billions EUR
FY21:
13.7
FY22:
16.5
FY23:
14.9
FY24:
15.7
FY25:
14.6
Total assets
Change from FY21 to FY25
billions EUR
FY21:
19.2
FY22:
21.2
FY23:
21.0
FY24:
21.4
FY25:
19.7

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions EUR
FY21:
3.47
FY22:
2.02
FY23:
2.33
FY24:
2.16
FY25:
2.02
(negative)
Change from FY21 to FY25
billions EUR
FY21:
8.44
FY22:
11.2
FY23:
11.2
FY24:
10.6
FY25:
10.1
(positive)
Change from FY21 to FY25
billions EUR
FY21:
7.32
FY22:
7.98
FY23:
7.51
FY24:
8.61
FY25:
7.60
Total liabilities & equity
Change from FY21 to FY25
billions EUR
FY21:
19.2
FY22:
21.2
FY23:
21.0
FY24:
21.4
FY25:
19.7

All amounts in billions EUR Data source:SEC EDGAR